<DOC>
	<DOCNO>NCT00592332</DOCNO>
	<brief_summary>Alprazolam ( Xanax ) blunt body 's ability defend low blood sugar .</brief_summary>
	<brief_title>Hypoglycemia Associated Autonomic Failure Type 1 DM , Q2</brief_title>
	<detailed_description>Due fundamental importance glucose cerebral fuel , complex redundant counterregulatory response hypoglycemia exist man . Some study show prior activation GABA ( A ) receptor may result blunt counterregulatory response next day hypoglycemia . The Specific Aim determine repeat activation GABA ( A ) receptor use Alprazolam result blunt neuroendocrine , ANS metabolic counterregulatory mechanism next day hypoglycemia T1DM healthy man .</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<criteria>16 ( 8 male , 8 female ) Type 1 diabetes patient aged 1845 yr. 16 ( 8 male , 8 female ) healthy control age 1845 yr. HbA1c &gt; 7.0 % ( Type 1 diabetes patient ) Had diabetes 215 year ( Type 1 diabetes patient ) No clinical evidence diabetic tissue complication ( Type 1 diabetes patient ) Body mass index 2130 kg Â· m2 Normal bedside autonomic function Normal result routine blood test screen hepatic , renal , hematological abnormality Female volunteer childbearing potential : negative HCG pregnancy test Prior history poor health : current prior disease condition alters carbohydrate metabolism prior cardiac event and/or evidence cardiac disease Hemoglobin le 12 g/dl Abnormal result follow screen test Pregnancy Subjects unable give voluntary inform consent Subjects know liver kidney disease Subjects take steroids Subjects take beta blocker Subjects anticoagulant drug , anemic , know bleeding disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>